Get Level 2
Less Ads, More Data, More Tools Register for FREE
REMOVE ADS
REMOVE ADS

Latest Share Chat

  2. Share Prices
  3. REDX.L Share Price
  4. REDX.L Share Regulatory News

Pin to quick picksREDX.L Regulatory News (REDX)

REDX.L Information
  • There is currently no data for REDX
12345678910
Date   Source Headline
13th Apr 201612:06 pmRNSResult of General Meeting and Issue of Equity
4th Apr 20162:58 pmRNSGrant of Options
4th Apr 201612:59 pmRNSResult of General Meeting
4th Apr 20167:00 amRNSIssue of Equity
29th Mar 20167:00 amRNSDirector/PDMR Shareholding
24th Mar 20161:55 pmRNSPlacing to Raise £10 Million
8th Mar 20167:00 amRNSChange of Adviser
24th Feb 201612:39 pmRNSResult of AGM
24th Feb 20167:00 amRNSAGM Statement
22nd Jan 20169:09 amRNSHardman & Co Research Report: Pipeline progress
22nd Jan 20167:30 amRNSHardman & Co Research Report: Pipeline progress
20th Jan 20167:00 amRNSFinal Results
6th Jan 20167:00 amRNSNotice of Results
4th Jan 20167:00 amRNSAppointment of Non-Executive Director
3rd Dec 20157:00 amRNSFourth drug development candidate
10th Nov 20157:00 amRNSRe BioInfect Conference 2015
5th Nov 20157:00 amRNSSenior management appointments
23rd Oct 20152:57 pmRNSRe Review on Antimicrobial Resistance
1st Oct 20157:00 amRNSTrading Update
3rd Sep 20157:00 amRNSCancer Research Collaboration with Redx Pharma
3rd Sep 20157:00 amRNSCancer Research Collaboration
22nd Jun 20157:00 amRNSHalf Yearly Report
19th Jun 20155:14 pmRNSHolding(s) in Company
4th Jun 20159:45 amRNSHolding(s) in Company
2nd Jun 20157:00 amRNSDiscovery of breakthrough MRSA compound
26th May 20157:01 amRNSSecond drug development candidate identified
14th May 20157:00 amRNSRe Review on Antimicrobial Resistance
14th May 20157:00 amRNSLaunch of third subsidiary, Redx Immunology
11th May 20157:00 amRNSPre-Clinical Proof of Concept with Oncology Lead
31st Mar 20155:13 pmRNSHolding(s) in Company
31st Mar 20151:35 pmRNSHolding(s) in Company
31st Mar 20151:33 pmRNSHolding(s) in Company
31st Mar 20159:37 amRNSHolding(s) in Company
27th Mar 20157:00 amRNSAdmission to AIM and First Dealings
12345678910

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Recently viewed
MACF
Macfarlane Grp.
LSE
-0.46%
JPSS
Jpmor. Jap.smls
LSE
0.00%
ATR
Schroder Asian
LSE
-1.74%
EGY
Vaalco Energy
LSE
-2.41%
EPWN
Epwin Grp
LSE
0.00%
Trending
MPL
Mercantile Ports & Logistics
LSE
26.92%
AVCT
Avacta Group
LSE
-1.40%
PREM
Premier African Minerals
LSE
-7.61%
HEX
Helix Exploration
LSE
-0.67%
FORG
Forgent
LSE
-5.26%